BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 16488716)

  • 41. Postoperative radiotherapy in non-small-cell lung cancer warrants further exploration in the era of adjuvant chemotherapy and conformal radiotherapy.
    Bonner JA; Spencer SA
    J Clin Oncol; 2006 Jul; 24(19):2978-80. PubMed ID: 16769984
    [No Abstract]   [Full Text] [Related]  

  • 42. Invited commentary.
    Putnam JB
    Ann Thorac Surg; 2007 Feb; 83(2):424. PubMed ID: 17257964
    [No Abstract]   [Full Text] [Related]  

  • 43. Invited commentary to CXCR4 expression study.
    Chou SH
    World J Surg; 2011 Jan; 35(1):62. PubMed ID: 21046384
    [No Abstract]   [Full Text] [Related]  

  • 44. Frequency of local recurrence following segmentectomy of stage IA non-small cell lung cancer is influenced by segment localisation and width of resection margins--implications for patient selection for segmentectomy.
    Sienel W; Stremmel C; Kirschbaum A; Hinterberger L; Stoelben E; Hasse J; Passlick B
    Eur J Cardiothorac Surg; 2007 Mar; 31(3):522-7; discussion 527-8. PubMed ID: 17229574
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Invited commentary.
    Lim E
    Ann Thorac Surg; 2007 Jan; 83(1):202-3. PubMed ID: 17184662
    [No Abstract]   [Full Text] [Related]  

  • 46. Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: focusing on an effect of the number of mediastinal lymph node stations involved.
    Matsuguma H; Nakahara R; Ishikawa Y; Suzuki H; Inoue K; Katano S; Yokoi K
    Interact Cardiovasc Thorac Surg; 2008 Aug; 7(4):573-7. PubMed ID: 18413349
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Is there a definitive answer to the question of involved-field radiotherapy for inoperable non-small-cell lung cancer?
    Lima CG; Cordova AL
    J Clin Oncol; 2008 May; 26(13):2235; author reply 2235-6. PubMed ID: 18445859
    [No Abstract]   [Full Text] [Related]  

  • 48. Results of primary surgery with T4 non-small cell lung cancer during a 25-year period in a single center: the benefit is worth the risk.
    Yildizeli B; Dartevelle PG; Fadel E; Mussot S; Chapelier A
    Ann Thorac Surg; 2008 Oct; 86(4):1065-75; discussion 1074-5. PubMed ID: 18805134
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Early-stage NSCLC. Resectable non-small cell lung cancers: (neo) adjuvant chemotherapy].
    Berghmans T
    Rev Mal Respir; 2008 Oct; 25(8 Pt 2):3S72-8. PubMed ID: 18971829
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic significance and possibility in guiding adjuvant therapy of the pleural lavage cytology in patients with non-small cell lung cancer.
    Nakamura T; Suzuki K; Mochizuki T; Ohde Y; Kobayashi H; Nakamura H; Toyoda F
    Interact Cardiovasc Thorac Surg; 2009 Mar; 8(3):321-4. PubMed ID: 19059950
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic factors in resected stage I non-small cell lung cancer with a diameter of 3 cm or less: visceral pleural invasion did not influence overall and disease-free survival.
    Hung JJ; Wang CY; Huang MH; Huang BS; Hsu WH; Wu YC
    J Thorac Cardiovasc Surg; 2007 Sep; 134(3):638-43. PubMed ID: 17723811
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Surgical assessment and intraoperative management of mediastinal lymph nodes in non-small cell lung cancer.
    Whitson BA; Groth SS; Maddaus MA
    Ann Thorac Surg; 2007 Sep; 84(3):1059-65. PubMed ID: 17720443
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Invited commentary.
    Pass H
    Ann Thorac Surg; 2008 Dec; 86(6):1744. PubMed ID: 19021968
    [No Abstract]   [Full Text] [Related]  

  • 54. Does lobectomy achieve better survival and recurrence rates than limited pulmonary resection for T1N0M0 non-small cell lung cancer patients?
    Chamogeorgakis T; Ieromonachos C; Georgiannakis E; Mallios D
    Interact Cardiovasc Thorac Surg; 2009 Mar; 8(3):364-72. PubMed ID: 18641014
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Early stages of non small cell lung cancer (I. II. IIIA). Postoperative treatments for resected non small-cell lung cancer].
    Barlési F
    Rev Mal Respir; 2006 Nov; 23(5 Pt 3):16S47-16S53. PubMed ID: 17268336
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic factors in resected satellite-nodule T4 non-small cell lung cancer.
    Rao J; Sayeed RA; Tomaszek S; Fischer S; Keshavjee S; Darling GE
    Ann Thorac Surg; 2007 Sep; 84(3):934-8; discussion 939. PubMed ID: 17720402
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Chemotherapy in cancer of the lung].
    Gütz S
    MMW Fortschr Med; 2006 Jun; 148(22):33-4. PubMed ID: 16821578
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Photons or protons: precision radiotherapy of lung cancer.
    Auberger T; Seydl K; Futschek T; Sztankay A; Sweeney RA; Lukas P
    Strahlenther Onkol; 2007 Dec; 183 Spec No 2():3-6. PubMed ID: 18166995
    [No Abstract]   [Full Text] [Related]  

  • 59. Surgical management of non-small cell lung cancer.
    Wagner KJ
    Semin Oncol Nurs; 2008 Feb; 24(1):41-8. PubMed ID: 18222151
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [NSCLC of early stage. The place of surgery].
    Riquet M; Scotte F
    Rev Mal Respir; 2008 Oct; 25(8 Pt 2):3S67-71. PubMed ID: 18971828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.